Evidence map›Paper›PMID 22275376›Full record

ArticleThe Journal of biological chemistry2012

A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.

Christina Pagiatakis, Joseph W Gordon, Saviz Ehyai, John C McDermott

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Inhibition of tiRNA-Gly-GCC ameliorates neointimal formationFrontiers in cardiovascular medicine · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christina PagiatakisDepartment of Biology, York University,Toronto M3J 1P3, Canada.
Joseph W Gordon
Saviz Ehyai
John C McDermott
York University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differentiation of vascular smooth muscle cells (VSMC) is a fundamental aspect of normal development and vascular disease. During contraction, VSMCs modulate calcium sensitivity through RhoA/ROCK-mediated inhibition of the myosin light chain phosphatase complex (MLCP). Previous studies have demonstrated that this signaling pathway functions in parallel to increase the expression of smooth muscle genes through the myocardin-family of co-activators. MEF2C fulfills a critical role in VSMC differentiation and regulates myocardin expression, leading us to investigate whether the RhoA/ROCK signaling cascade might regulate MEF2 activity. Depolarization-induced calcium signaling increased the expression of myocardin, which was sensitive to ROCK and p38 MAPK inhibition. We previously identified protein phosphatase 1α (PP1α), a known catalytic subunit of the MLCP in VSMCs, as a potent repressor of MEF2 activity. PP1α inhibition resulted in increased expression of myocardin, while ectopic expression of PP1α inhibited the induction of myocardin by MEF2C. Consistent with these data, shRNA-mediated suppression of a PP1α inhibitor, CPI-17, reduced myocardin expression and inhibited VSMC differentiation, suggesting a pivotal role for CPI-17 in regulating MEF2 activity. These data constitute evidence of a novel signaling cascade that links RhoA-mediated calcium sensitivity to MEF2-dependent myocardin expression in VSMCs through a mechanism involving p38 MAPK, PP1α, and CPI-17.

Indexed as

AnimalsCell DifferentiationChlorocebus aethiopsCOS CellsGene Expression RegulationHumansIntracellular Signaling Peptides and ProteinsMADS Domain ProteinsMAP Kinase Signaling SystemMEF2 Transcription FactorsMiceMuscle ProteinsMuscle, Smooth, VascularMyocardinMyocytes, Smooth MuscleMyogenic Regulatory FactorsIntracellular Signaling Peptides and ProteinsMADS Domain ProteinsMEF2C protein, humanMef2c protein, mouseMEF2C protein, ratMEF2 Transcription FactorsMuscle ProteinsMyocardinMyogenic Regulatory FactorsNuclear Proteinsp38 Mitogen-Activated Protein KinasesPhosphoprotein PhosphatasesPhosphoproteinsPPP1R14A protein, humanPpp1r14a protein, mousePpp1r14a protein, ratrhoA GTP-Binding ProteinRHOA protein, humanRhoA protein, mouserho-Associated Kinasesrho GTP-Binding ProteinsTrans-Activators

Identifiers

PMID22275376
PMCPMC3318694
OpenAlexW2066715566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.